Valve technology in children: we need to change the paradigm
Summary of the October 2022 meeting between the Heart Valve Collaboratory (HVC) working group and the FDA.
Summary of the October 2022 meeting between the Heart Valve Collaboratory (HVC) working group and the FDA.
A meta-analysis of 11 studies confirms the superiority of the GERAADA score over EuroSCORE II for predicting 30-day surgical risk in patients with acute aortic dissection.
This study aimed to retrospectively evaluate the mechanisms of repair failure in a cohort of 344 patients who underwent isolated mitral valve repair.
This retrospective observational study compared midterm outcomes after aortic valve replacement (AVR) with annular enlargement versus isolated AVR in 124 surgically treated patients.
Visual and annotated summary of a surgical tutorial video on the explantation of the HeartMate 3 during orthotopic heart transplantation, complemented by recent evidence on surgical approaches, explant techniques, and clinical outcomes.
Critical analysis of the randomized ACCESS-TAVI trial, published in the European Heart Journal, which compares two femoral closure strategies after transfemoral TAVI.
Results from the first randomized trial assessing transfemoral TAVR in patients with moderate aortic stenosis and ventricular dysfunction.
This retrospective study analyzed more than three thousand patients who underwent surgical mitral valve repair for degenerative mitral regurgitation, with a 10-year follow-up.
This article proposes an optimized management strategy for patients with type A aortic dissection complicated by malperfusion syndrome (MPS), structured around a 6-hour threshold from symptom onset.
Surgical outcomes from the past 25 years of the European Congenital Heart Surgeons Association Congenital Cardiac Database